AGP Executive Report

Activity & Mental Health: A global study found Chinese adults spend 90% of their waking hours inactive, with severe inactivity linked to lower mental well-being. It also found 15 minutes of daily exercise can bring measurable benefits. Care for Older Adults: China has unveiled a plan to expand rehabilitation and nursing services, while a Beijing community introduced a one-button emergency call system for older residents. Drug Innovation: China is targeting five billion-dollar innovative drugs by 2030 as its biotech industry expands globally. Global Health: China has nominated health official Song Li for WHO director-general, as its naval hospital ship completes a medical mission in Guinea.

Food Safety: China recorded a second carp-linked Haff disease cluster, with five people developing rhabdomyolysis after eating wild red-tailed carp. Nutrition Research: Researchers at Chinese universities found mushroom-derived peptides made salt taste up to 71% stronger in lab tests, a potential route to lower-sodium foods. Biotech: China is targeting five innovative drugs with billion-dollar sales by 2030, as its pharmaceutical industry expands globally. Aging Care: A Beijing community has introduced a one-button emergency call system to help older residents get assistance. Global Health: China has nominated health official Song Li for the WHO leadership race.

AI & Prevention: Researchers at Shanghai’s Changzheng Hospital found that commercial AI can assess osteoporosis risk from routine CT scans, potentially flagging people who might otherwise miss bone-density screening. Biotech: China aims to develop at least five innovative drugs with annual global sales above $1 billion by 2030, as domestic firms attract more international licensing deals. Health Leadership: China has nominated senior health official Song Li to run for WHO director-general in 2027. Care for Older Adults: China plans to expand rehabilitation and hospice services; a Beijing doctor says his team supports terminally ill patients with pain care and psychological and social support. Medical Technology: Midea completed its acquisition of a controlling stake in Italian imaging firm Esaote, adding ultrasound and MRI products to its healthcare business. Global Health: China pledged Kenya $2 million for Ebola preparedness and drought relief.

Emergency Care: Philippine officials say a Navy sailor’s evacuation from Ayungin Shoal was delayed more than 10 hours after Chinese vessels blocked rescue efforts; he was eventually flown to hospital. Food Safety: China CDC reported a second carp-linked Haff disease cluster, with five people developing rhabdomyolysis after eating wild red-tailed carp. Medical Innovation: A Chinese eye implant reportedly helped a blind man recognize letters and avoid obstacles, while a separate brain-computer interface project aims to restore vision. Global Health: China has nominated senior health official Song Li to lead the WHO, renewing scrutiny of her COVID-era record. Care Services: China has outlined plans to expand rehabilitation and nursing services.

WHO Leadership: China has nominated senior health official Song Li to run for WHO director-general, bringing Beijing’s pandemic record back into focus as the leadership race takes shape. Food Safety: China’s CDC reported a second cluster of suspected Haff disease linked to wild red-tailed carp, with five people developing rhabdomyolysis after eating the fish. Care Services: Beijing has unveiled plans to expand rehabilitation and nursing services, addressing growing demand for long-term and recovery care. Infectious Disease Watch: After a worker died at a Siberian anti-plague institute, China said the risk of an outbreak reaching the country was very low and confirmed health cooperation with Russia. Emergency Care: Philippine officials say Chinese Coast Guard vessels delayed a medical evacuation from Ayungin Shoal for nearly 10 hours; the sick sailor was later transferred and flown to hospital.

WHO Leadership: China has nominated senior health official Song Li to succeed Tedros Adhanom Ghebreyesus when the WHO elects its next director-general in May 2027. Song has worked on maternal and child health, international cooperation and responses to major health emergencies. Cancer Care: China’s drug regulator approved datopotamab deruxtecan for some patients with metastatic triple-negative breast cancer and trastuzumab deruxtecan as adjuvant treatment for certain patients with early HER2-positive disease. Care Services: China unveiled a plan to expand and improve rehabilitation and nursing services. Disease Preparedness: China is giving Kenya a $2 million grant, with half earmarked for Ebola preparedness and half for drought response, as Kenya manages an imported Ebola case.

Care Services: China’s new plan aims for large cities to have at least one public rehabilitation hospital and nursing facility by 2030, while expanding beds and training more rehabilitation staff. WHO Leadership: Beijing nominated National Health Commission official Song Li to lead the World Health Organization, presenting her candidacy as support for multilateral health cooperation. Research: A study involving Sun Yat-sen University researchers found that a gut bacterium and a molecule it produces reduced cholesterol and arterial plaque in mice; the findings are not yet a treatment for people. Youth Mental Health: Reports of student suicides in several Chinese cities have renewed concern over academic and family pressure, as some high schools extended the National Day break. Disease Monitoring: The WHO is seeking more information from Russia about a suspected pneumonic plague case, while China says it is maintaining infectious-disease exchanges with Moscow.

Plague Watch: China says it is in close contact with Russia on infectious-disease prevention, including plague, after a Siberian lab worker died of pneumonia. Plague has not been confirmed; Russia says testing found no dangerous pathogen, while WHO says it still needs more information. Healthy Aging: A six-year study of older adults in China found that a low bioelectrical “phase angle” was linked to higher future sarcopenia risk, suggesting a possible early warning measure that needs further validation. Food and Nutrition: Researchers at Chengdu University found that changing how buckwheat noodles are fermented can slow starch digestion, a potential way to make a popular staple more blood-sugar-friendly. Global Health Leadership: China is preparing a late bid to lead WHO, putting its role in international health cooperation in focus.

Hong Kong Primary Care Push: Hong Kong is expanding its “Family Doctor for All” model, growing its Primary Care Directory and adding more community-based preventive care plus digital health services to strengthen chronic disease support and maternal/child healthcare. Plague Watch (China-linked global health): Reports of a Siberian plague-lab worker’s death have triggered quarantine and international calls for transparency; public health authorities say there are no confirmed plague cases among contacts, while officials debate what happened. Parkinson’s Risk Clue: A new analysis using China Kadoorie Biobank data links smoking’s lower Parkinson’s risk to possible roles of carbon monoxide, adding to the search for the protective mechanism. Dementia Prevention Tip: Research suggests faster walking—especially stronger leg push—may slow cognitive decline in people at high risk for dementia. Biotech/Clinical Pipeline: Dimerix says its lead kidney-disease candidate has reached longer continuous dosing data after completing blinded and open-label phases. Medical Devices (EU MDR): ClaroNav Kolahi received EU MDR certification for its Navient surgical navigation system, expanding access across Europe. Food & Metabolic Health: Mengniu is promoting a probiotic strain tied to GLP-1 secretion, signaling more “GLP-1 era” functional dairy ambitions in China.

Pneumonic Plague Watch: WHO says a suspected pneumonic plague case tied to a Russian anti-plague lab death poses a “very low” risk outside Russia, while authorities quarantine facilities and monitor contacts. Cancer Care & Drug Trials: ArriVent’s firmonertinib lung-cancer pill missed a key Phase 3 goal on progression-free survival, though response rates looked stronger at the higher dose; separate CAR-T research highlights efforts to improve access and speed with off-the-shelf approaches. Biotech Manufacturing Moves: Alvotech and LOTTE Biologics announced a long-term US manufacturing partnership to expand biosimilar antibody production capacity. Digital Health & Trials: A podcast discussion spotlights AI for patient recruitment and enrollment predictability, contrasting workflow automation with real-world decision-making risks. Public Health & Safety: Reports of garbage dumping in Hyderabad’s open residential plots raise mosquito and infection concerns, while WHO’s plague update keeps infectious-disease preparedness in focus. Health System Capacity: A Navy readiness command completed its first Basic Vaccinator Course to expand qualified vaccinators and improve immunization readiness.

New Professions in China: China’s eighth batch of new occupations highlights health-adjacent tech demand, from AI engineering technicians to microgrid administrators and low-altitude logistics roles, reflecting fast industrial upgrading. Breast Cancer Awareness (Hong Kong): The Centre for Health Protection urged women to adopt healthier lifestyles and use risk-based screening; it cited strong survival rates, especially for early-stage disease. HPV Persistence Signals (China study): Research from Taihe Hospital of Hubei Medical University links high-risk HPV persistence to differences in vaginal microbiota and metabolic profiles, including Lactobacillus iners. Plague Alert in Russia, Monitored by Latvia: Latvia’s health authority said international spread risk is very low while Russia quarantines a Siberian hospital and monitors contacts after a lab worker’s death amid conflicting reports. Cancer Drug Update (HLB): HLB shares jumped after the FDA closed out a routine inspection for rivoceranib with a “voluntary action indicated” outcome, paving the way for a US refile. Workplace Safety Tech (Port, Korea): CyberLogitec deployed AI collision prevention at Busan’s container terminal, using digital-twin monitoring to reduce vehicle–worker incidents. Green Space & Dementia (Sweden cohort): A long-running study found more nearby vegetation is linked to lower dementia risk in older adults, with stronger effects in women.

Optogenetics Breakthrough: The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth and colleagues for optogenetics, a tool that lets scientists control specific cells with light—opening new paths for treating disorders like Parkinson’s and epilepsy. Biotech Dealmaking: Novartis signed a licensing deal worth up to $7.8B with China’s Abogen Biosciences for an mRNA autoimmune therapy (ABO2203), signaling continued global demand for Chinese immunology pipelines. Clinical Trial Acceleration: The U.S. FDA launched an expedited IND pilot (“Operation TrialBlazer”) to speed early clinical trial entry—an effort to keep pace with countries including China. Diabetes Drug Results: Orforglipron showed stronger A1C and weight reductions than oral semaglutide in a phase 3 trial, with data spanning multiple countries including China. Public Health Watch: U.S. officials are monitoring a reported pneumonic plague death in Russia tied to an anti-plague lab, while information-sharing remains limited. Food & Health: A study links higher cat density with greater happiness in wealthier countries, but notes sadness rises where exposure to the cat parasite Toxoplasma gondii is higher.

Plague Alert (Russia): A 28-year-old lab technician in Irkutsk, Siberia, has died of plague, with up to 200 close contacts reportedly quarantined—raising alarm over potentially pneumonic spread. AI in Imaging (China): Two-center research suggests AI can infer breast cancer subtypes from routine ultrasound and DCE-MRI, potentially reducing the need for biopsy-first decisions. Cancer Burden (China/US): A new comparative analysis maps how pancreatic cancer incidence, mortality and disability burden have diverged between China and the United States from 1990–2023, with age-adjusted rates higher in the US. Genetic/Biosecurity (China): China’s security ministry warns of genetic resource theft and cross-border biosecurity risks, signaling tighter oversight for international life-science activity. Healthcare Access & Trials (US/China-linked): FDA approval expands US manufacturing capacity for SIMLANDI® (adalimumab biosimilar), while broader debate continues over how to keep patients able to access new drugs and speed clinical trials. Food & Wellness (Hong Kong): A “movement snacks” concept targets desk workers, challenging the 10,000-step myth with short activity bursts. Public Health & Policy (China): China’s National Day coverage also highlights embodied AI robots in public spaces and ongoing efforts to modernize services.

Cancer Care Update: A Shanxi Province Cancer Hospital study in BMC Cancer reports that adding tislelizumab (PD-1) to chemo plus bevacizumab may extend survival for recurrent cervical cancer patients. Mental Health & Oncology: A multicenter China study in Supportive Care in Cancer links worsening emotional distress over the course of neoadjuvant therapy and surgery with poorer survival in resectable non–small cell lung cancer. Infectious Disease Watch: Hong Kong’s SSM says an 82-year-old man returning from China developed Legionnaires’ disease and is in critical condition; family members report no symptoms. Biosecurity Alert: China’s Ministry of State Security warns of overseas attempts to steal genetic resources, including smuggling human blood samples and bringing in exotic pets/plant seeds without proper approvals. Regulatory/Industry: Novartis signed a deal worth up to $7.8B with China’s Abogen for mRNA-based therapies, highlighting continued big pharma interest in Chinese RNA platforms. Health Workforce/Access: China’s “Hundred Days, Ten Million Jobs” campaign held online job fairs including healthcare, drawing thousands of employers and openings.

Vaccine Capacity: Nigeria’s NAFDAC urged international partners to fund modular vaccine manufacturing (especially fill-and-finish) to reach WHO vaccine lot-release maturity, warning local production gaps slow progress. Counterfeit Crackdown: Nigeria faces a surge of fake food, drugs, and consumer goods; NAFDAC says it has destroyed large volumes and secured convictions, while critics call for stronger, more sustained enforcement. Medical Tech: Tianjin University unveiled a 3-gram non-invasive brain-computer interface hidden in hair, aiming for longer, more comfortable EEG monitoring. Traditional Medicine Quality Control: Hong Kong’s Chinese Medicines Testing Institute expanded rapid DNA testing for Lu Rong, cutting verification time from days to under one day. Maternal Health Research: A study links gut-derived butyrate to improved glucose control in pregnancy, offering new angles for gestational diabetes prevention. Antimicrobial Materials: Zhejiang Sci-Tech researchers reported zinc-oxide quantum-dot polymer wipes out bacteria and fungi at antibiotic-like levels in lab tests. Public Health & Care Access: China’s naval hospital ship Auspicious Ark arrived in Guinea to deliver medical services and training during a week-long visit. Community Wellness: A Lahaina workshop used traditional Chinese medicine for respiratory health, combining acupuncture, breathwork, and at-home tools. Health-Adjacent Policy: China opened an anti-dumping probe into EU chemical imports (p-nitrotoluene), a move that could affect supply chains for pharma and pesticides.

Space Health & Nutrition: China’s space station “Tiangong” is getting more home-like as astronauts now eat nearly 200 dishes, including familiar favorites like Kung Pao chicken and mapo tofu, with viral clips showing freshly cooked meals in orbit. Reproductive Health: A study reports that frozen embryo transfers prepared with hormone replacement therapy produce babies with similar early childhood intelligence outcomes to natural-cycle methods, but are linked to more unusually large babies and more newborn care admissions. Public Health & Safety: Parents are being warned about “squishy” sensory toys sold online with medical syringes/needles, after concerns that children can get pierced and consumer protection officials move to investigate. Medical Innovation (Longevity): VSee launches MorePerfect.ai to connect longevity clinics and researchers across Asia-Pacific, letting them pool anonymized “body twin” data while keeping each clinic in control of what’s shared. Global Health Cooperation: China’s PLA Navy hospital ship Auspicious Ark arrives in Guinea for a seven-day medical mission, including services plus training and outreach. Trade/Health Industry: China launches an anti-dumping probe into EU imports of p-nitrotoluene, a chemical used for dyes, pesticides and pharmaceuticals.